Om Research

Lancaster, California 93594

1 studies enrolling now · 9 studies all time

What they study most

Crohn Disease, Crohn's Disease, Cyclic Vomiting Syndrome, Indeterminate Colitis, Inflammatory Bowel Diseases, Metabolic Dysfunction-associated Steatohepatitis, Nonalcoholic Steatohepatitis, Primary Biliary Cholangitis, Ulcerative Colitis, Ulcerative Proctitis, Weight, Body

Studies at this site

• A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH) — Recruiting now
• Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories — Completed
• Long-term Antipsychotic Pediatric Safety Trial — Completed
• A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease — Running, not enrolling
• Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis — Completed
• Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome — Completed
• AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis — Completed
• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early